ES8401134A1 - "metodo de producir un cultivo transformante de celulas de vertebrado". - Google Patents

"metodo de producir un cultivo transformante de celulas de vertebrado".

Info

Publication number
ES8401134A1
ES8401134A1 ES515260A ES515260A ES8401134A1 ES 8401134 A1 ES8401134 A1 ES 8401134A1 ES 515260 A ES515260 A ES 515260A ES 515260 A ES515260 A ES 515260A ES 8401134 A1 ES8401134 A1 ES 8401134A1
Authority
ES
Spain
Prior art keywords
hbsag
cell culture
gene
vertebrate cell
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515260A
Other languages
English (en)
Other versions
ES515260A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26970555&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8401134(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES515260A0 publication Critical patent/ES515260A0/es
Publication of ES8401134A1 publication Critical patent/ES8401134A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE CULTIVOS TRANSFORMANTES DE CELULAS DE VERTEBRADO, CAPACES DE PRODUCIR POLIPEPTIDOS, POR EXPRESION DE VECTORES DE EXPRESION REPLICABLES, QUE CODIFICAN LOS POLIPEPTIDOS.CONSISTE EN PREPARAR UN FRAGMENTO DE VECTOR DE TRANSFERENCIA DE ADN CAPAZ DE REPLICACION DE UN CULTIVO DE CELULAS HOSPEDANTES. PREPARAR UN FRAGMENTO DE ADN QUE CONTIENE UN PROMOTOR COMPATIBLE CON EL CULTIVO, Y UN FRAGMENTO DE ADN QUE CODIFICA UN POLIPEPTIDO ADECUADO. REUNIR Y MONTAR LOS FRAGMENTOS PARA FORMAR UN VECTOR DE EXPRESION BAJO EL CONTROL DEL PROMOTORY TRANSFORMAR EL CULTIVO DE CELULAS DE VERTEBRADOS CON EL VECTOR.ESTOS ANTIGENOS TIENEN APLICACIONES PARA LA PREPARACION DE VACUNAS CONTRA VIRUS DE HEPATITIS B.
ES515260A 1981-08-31 1982-08-26 "metodo de producir un cultivo transformante de celulas de vertebrado". Expired ES8401134A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29823581A 1981-08-31 1981-08-31
US32698081A 1981-12-03 1981-12-03

Publications (2)

Publication Number Publication Date
ES515260A0 ES515260A0 (es) 1983-12-01
ES8401134A1 true ES8401134A1 (es) 1983-12-01

Family

ID=26970555

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515260A Expired ES8401134A1 (es) 1981-08-31 1982-08-26 "metodo de producir un cultivo transformante de celulas de vertebrado".

Country Status (17)

Country Link
EP (2) EP0073656B1 (es)
JP (3) JPS5856685A (es)
AU (2) AU555575B2 (es)
BR (1) BR8205078A (es)
DE (1) DE3280310D1 (es)
DK (1) DK173592B1 (es)
ES (1) ES8401134A1 (es)
GB (1) GB2105344B (es)
GR (1) GR76906B (es)
HK (1) HK29689A (es)
HU (1) HU196238B (es)
IE (1) IE53873B1 (es)
IL (1) IL66637A (es)
KE (1) KE3838A (es)
NO (1) NO165598C (es)
NZ (1) NZ201706A (es)
ZW (1) ZW18282A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196194A (en) * 1979-05-24 1993-03-23 The Regents Of The University Of California Vaccines containing Hepatitis B S-protein
US4769238A (en) 1981-08-04 1988-09-06 The Regents Of The University Of California Synthesis of human virus antigens by yeast
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
JPS5936698A (ja) * 1982-08-20 1984-02-28 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えｄｎａおよび形質転換動物細胞
CA1209501A (en) * 1982-09-16 1986-08-12 Nikos Panayotatos Expression vector
US4820642A (en) * 1983-04-04 1989-04-11 The Regents Of The University Of California Amplified expression vector
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209308A (en) 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
WO1985001516A1 (fr) * 1983-10-03 1985-04-11 Transgene S.A. Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin
FR2552776B1 (fr) * 1983-10-03 1986-05-09 Transgene Sa Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
US5639639A (en) * 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US5118627A (en) * 1984-02-27 1992-06-02 Amgen Papova virus construction
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
US4663281A (en) * 1984-03-22 1987-05-05 Mass Institute Of Technology Enhanced production of proteinaceous materials in eucaryotic cells
FR2564106B1 (fr) * 1984-05-09 1988-04-22 Transgene Sa Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix.
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
WO1986006405A1 (en) * 1985-05-02 1986-11-06 Takeda Chemical Industries, Ltd. Novel transformant and its use
EP0213628A3 (en) * 1985-09-03 1988-09-21 Yeda Research And Development Company, Ltd. Expression of superoxide dismutase in eukaryotic cells
SE8505027D0 (sv) * 1985-10-24 1985-10-24 Kabigen Ab A lytic virulent phage, a hostcell containing same and a process for protein production
EP0228036A3 (en) * 1985-12-18 1988-09-07 Microgenesys, Inc. Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
AU582288B2 (en) * 1986-03-07 1989-03-16 Damon Biotech Inc. Vector and method for achieving high level expression in eukaryotic cells
US5004693A (en) * 1986-07-18 1991-04-02 E. I. Du Pont De Nemours And Company Pseudorabies virus recombinants and their use in the production of proteins
NZ219516A (en) * 1987-02-10 1991-02-26 Wellcome Found Fusion proteins of hbcag (hepatitis b virus core antigen)
US5024939A (en) * 1987-07-09 1991-06-18 Genentech, Inc. Transient expression system for producing recombinant protein
US5578468A (en) * 1987-08-10 1996-11-26 Duke University Site-specific RNA cleavage
US5443964A (en) * 1987-08-10 1995-08-22 Duke University Poxvirus insertion/expression vector
JPH01285196A (ja) * 1988-05-11 1989-11-16 Chisso Corp 発光蛋白エクオリンの製造法
US5709995A (en) 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
JP4085231B2 (ja) * 2000-02-28 2008-05-14 株式会社ビークル タンパク質中空ナノ粒子とそれを用いた物質運搬体、ならびに細胞への物質導入方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US4164565A (en) * 1975-03-14 1979-08-14 New York Blood Center, Inc. Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
FR2444713A1 (fr) 1978-12-18 1980-07-18 Pasteur Institut Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
ES8105035A1 (es) * 1978-12-22 1981-05-16 Biogen Nv Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv
IE52036B1 (en) 1979-05-24 1987-05-27 Univ California Non-passageable viruses
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
US4399216A (en) * 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811895B (en) * 1980-04-07 1982-04-28 Univ California Expression of hormone genomic clones
FR2480780B1 (fr) * 1980-04-22 1985-12-06 Pasteur Institut Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
EP0038765B1 (fr) * 1980-04-22 1987-09-02 Institut Pasteur Vaccin contre l'hépatite virale B, procédé et cellules eucaryotes transformées pour la production de ce vaccin
EP0062574A3 (en) * 1981-03-31 1982-12-29 The Regents Of The University Of California Virus protein synthesis
JPS5813598A (ja) * 1981-06-22 1983-01-26 イーライ・リリー・アンド・カンパニー 組み替えｄｎａクロ−ニング・ベクタ−ならびにその真核細胞性および原核細胞性被形質転換体
ZW18282A1 (en) 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
FR2521165A1 (fr) * 1982-02-08 1983-08-12 Pasteur Institut Fragments d'adn codant pour un peptide immunogene susceptible d'introduire in vivo la synthese d'anticorps anti-poliovirus
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes

Also Published As

Publication number Publication date
DK386982A (da) 1983-03-01
JP2634371B2 (ja) 1997-07-23
JPS5856685A (ja) 1983-04-04
AU589673B2 (en) 1989-10-19
EP0291586A2 (en) 1988-11-23
IL66637A (en) 1991-11-21
BR8205078A (pt) 1983-08-09
ES515260A0 (es) 1983-12-01
HK29689A (en) 1989-04-14
JPH0587518B2 (es) 1993-12-16
NO822926L (no) 1983-03-01
GB2105344A (en) 1983-03-23
EP0073656A3 (en) 1984-10-24
ZW18282A1 (en) 1983-03-23
AU8779882A (en) 1983-03-10
AU6167186A (en) 1987-01-08
KE3838A (en) 1988-12-02
IL66637A0 (en) 1982-12-31
DE3280310D1 (de) 1991-04-11
GB2105344B (en) 1985-10-09
NZ201706A (en) 1986-05-09
GR76906B (es) 1984-09-04
NO165598B (no) 1990-11-26
HU196238B (en) 1988-10-28
EP0291586A3 (en) 1988-12-07
NO165598C (no) 1991-03-06
DK173592B1 (da) 2001-04-09
EP0073656B1 (en) 1991-03-06
IE822084L (en) 1983-02-28
JPH0937777A (ja) 1997-02-10
JPH06261748A (ja) 1994-09-20
JP2726641B2 (ja) 1998-03-11
AU555575B2 (en) 1986-10-02
IE53873B1 (en) 1989-03-29
EP0073656A2 (en) 1983-03-09

Similar Documents

Publication Publication Date Title
ES8401134A1 (es) "metodo de producir un cultivo transformante de celulas de vertebrado".
US4686186A (en) Recombinant vector and eukaryotic host transformed thereby
ES474852A1 (es) Un metodo para la expresion,en un huesped bacteriano trans- formado de un polipeptido heterologo con respecto al huespeden su estado no transformado
KR850003163A (ko) 완전변이 표현 콘트롤 시스템
Sarkar et al. Identification of a new polypeptide coded by reovirus gene S1
CA2349838A1 (en) Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
DK496886D0 (da) Udtrykkelse og sekretion af heterologe proteiner ved hjaelp af yarrowia lipolytica transformanter
JP2023174662A (ja) リシン誘導体を効率的に導入するアミノアシル－ｔＲＮＡシンテターゼ
DE3072070D1 (en) Plasmid vectors, plasmids containing genes for alkaline phosphatases and bacteria containing the latter, their preparation and use
KR840005745A (ko) B형 간염비루스 유전자를 삽입한 조환 플라스미드, 이 조환 플라스미드로 전환된 효모 및 b형 간염비루스 표면항원의 제조방법
CA2266342A1 (en) Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
KR920703830A (ko) 형질 발현 시스템
US5126251A (en) Stable mammalian cell line expressing a bacteriophage RNA polymerase
Perry et al. Non-toxic expression in Escherichia coli of a plasmid-encoded gene for phage T4 lysozyme
MX2010012517A (es) Adenovirus auxiliares auto-inactivantes para la produccion de adenovirus recombinantes de alta capacidad.
Berkhout et al. Translational interference at overlapping reading frames in prokaryotic messenger RNA
Trojanowska et al. The bacteriophage T4 regA gene: primary sequence of a translational repressor
US5118627A (en) Papova virus construction
IE831099L (en) Cloning vehicles for polypeptide expression in microbial¹hosts
EP0217529A1 (en) Expression vectors for use in E, coli
CA2033069A1 (en) Saf polypeptide, gene, promoter and use for expression in streptomyces
Seregin et al. Comparative studies of gamma-interferon receptor-like proteins of variola major and variola minor viruses
Jian et al. The hygromycin-resistance-eneoding gene as a selection marker for vaccinia virus recombinants
CA2373026A1 (en) Viral expression vectors
Sedláček et al. Processed enzymatically active protease (p15 gag) of avian retrovirus obtained in an E. coli system expressing a recombinant precursor (Pr25 lac‐Δgag)

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20030903